Dr David Sim
Cardiologist, Heart Failure Program Director, National Heart Center Singapore; Immediate past president of Heart Failure Society (Singapore)
Related Links
- Optimising GDMT Post AHF Discharge – APAC APSC Consensus Highlights
- EMPORIUM – Full Throttle Against HF: From Detection to Protection
- Value of NT-ProBNP for Treatment Monitoring in CHF
- Uncovering the Risk: Heart Failure in Diabetic Patients: Value of the cardiac biomarker NT-proBNP
- アジアにおける心不全 – 現在の課題と将来の戦略
- 아시아에서의 심부전 – 현재의 문제와 미래의 전략
- Heart Failure in Asia – Present Challenges and Future Strategies
- Dr David Simの臨床症例：心不全患者におけるNT-proBNP
- Dr David Sim’s Clinical Cases: NT-proBNP in Heart Failure Patients
- David Sim 박사의 임상 사례: 심부전 환자들에서의 NT-proBNP 검사 실시
- FAQ: NT-proBNP vs Cardiac Medications
- FAQ：NT-proBNPと心疾患治療薬との関連
- FAQ : NT-proBNP vs 심장 약제
- FAQ: Role of NT-proBNP in Heart Failure Management
- FAQ：心不全管理におけるNT-proBNPの役割
- FAQ: 심부전 관리에서 NT-proBNP의 역할
